Flow-independent nitric oxide exchange parameters in cystic fibrosis

Hye Won Shin, Christine M. Rose-Gottron, Ramindrjit S. Sufi, Federico Perez, Dan M. Cooper, Archie F. Wilson, Steven George

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Exhaled nitric oxide (NO) remains a promising noninvasive index for monitoring inflammatory lung diseases; however, the plateau concentration (CNo,plat) is nonspecific and requires a constant exhalation flow rate. We utilized a new technique that employs a variable flow rate to estimate key flow-independent parameters characteristic of NO exchange in a group (n = 9) of 10 to 14 yr-old healthy children and children with cystic fibrosis (CF). maximum flux of NO from the airways (JNo,max, pl s-1), diffusing capacity of NO in the airways (DNo,air, pl s-1 ppb-1), steady-state alveolar concentration (Calv,ss, ppb), and mean tissue concentration of NO in the airways (Ctiss,air, ppb). We determined the following mean (± SD) values in the healthy children and patients with CF for JNo,max, DNo,air, C̄alv,ss, and C̄tiss,air, respectively; 784 ± 465 and 607 ± 648 pl s-1; 4.82 ± 3.07 and 17.6 ± 12.1 pl s-1 ppb-1; 4.63 ± 3.59 and 1.96 ± 1.18 ppb; and 198 ± 131 and 38 ± 25 ppb. DNo,air is elevated (p = 0.007), and both Calv,ss and C̄tiss,air are reduced (p = 0.05 and 0.002, respectively) in CF. In contrast, CNO,plat for healthy control subjects and patients with CF are not statistically different at both exhalation flow rates of 50 ml/s (17.5 ± 11.5 and 11.5 ± 8.97) and at 250 ml/s (7.11 ± 5.36 and 4.28 ± 3.43). We conclude that DNo,air, C̄tiss,air, and Calv,ss may be useful noninvasive markers of CF.

Original languageEnglish (US)
Pages (from-to)349-357
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume165
Issue number3
DOIs
StatePublished - Feb 1 2002

Fingerprint

Cystic Fibrosis
Nitric Oxide
Air
Exhalation
Lung Diseases
Healthy Volunteers

Keywords

  • Airways
  • Healthy children
  • Inflammation
  • Nitric oxide
  • Parameter estimation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Flow-independent nitric oxide exchange parameters in cystic fibrosis. / Shin, Hye Won; Rose-Gottron, Christine M.; Sufi, Ramindrjit S.; Perez, Federico; Cooper, Dan M.; Wilson, Archie F.; George, Steven.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 165, No. 3, 01.02.2002, p. 349-357.

Research output: Contribution to journalArticle

Shin, Hye Won ; Rose-Gottron, Christine M. ; Sufi, Ramindrjit S. ; Perez, Federico ; Cooper, Dan M. ; Wilson, Archie F. ; George, Steven. / Flow-independent nitric oxide exchange parameters in cystic fibrosis. In: American Journal of Respiratory and Critical Care Medicine. 2002 ; Vol. 165, No. 3. pp. 349-357.
@article{fcd76c7297784ba79fc23f7474983ff8,
title = "Flow-independent nitric oxide exchange parameters in cystic fibrosis",
abstract = "Exhaled nitric oxide (NO) remains a promising noninvasive index for monitoring inflammatory lung diseases; however, the plateau concentration (CNo,plat) is nonspecific and requires a constant exhalation flow rate. We utilized a new technique that employs a variable flow rate to estimate key flow-independent parameters characteristic of NO exchange in a group (n = 9) of 10 to 14 yr-old healthy children and children with cystic fibrosis (CF). maximum flux of NO from the airways (JNo,max, pl s-1), diffusing capacity of NO in the airways (DNo,air, pl s-1 ppb-1), steady-state alveolar concentration (Calv,ss, ppb), and mean tissue concentration of NO in the airways (Ctiss,air, ppb). We determined the following mean (± SD) values in the healthy children and patients with CF for JNo,max, DNo,air, C̄alv,ss, and C̄tiss,air, respectively; 784 ± 465 and 607 ± 648 pl s-1; 4.82 ± 3.07 and 17.6 ± 12.1 pl s-1 ppb-1; 4.63 ± 3.59 and 1.96 ± 1.18 ppb; and 198 ± 131 and 38 ± 25 ppb. DNo,air is elevated (p = 0.007), and both Calv,ss and C̄tiss,air are reduced (p = 0.05 and 0.002, respectively) in CF. In contrast, CNO,plat for healthy control subjects and patients with CF are not statistically different at both exhalation flow rates of 50 ml/s (17.5 ± 11.5 and 11.5 ± 8.97) and at 250 ml/s (7.11 ± 5.36 and 4.28 ± 3.43). We conclude that DNo,air, C̄tiss,air, and Calv,ss may be useful noninvasive markers of CF.",
keywords = "Airways, Healthy children, Inflammation, Nitric oxide, Parameter estimation",
author = "Shin, {Hye Won} and Rose-Gottron, {Christine M.} and Sufi, {Ramindrjit S.} and Federico Perez and Cooper, {Dan M.} and Wilson, {Archie F.} and Steven George",
year = "2002",
month = "2",
day = "1",
doi = "10.1164/ajrccm.165.3.2105098",
language = "English (US)",
volume = "165",
pages = "349--357",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Flow-independent nitric oxide exchange parameters in cystic fibrosis

AU - Shin, Hye Won

AU - Rose-Gottron, Christine M.

AU - Sufi, Ramindrjit S.

AU - Perez, Federico

AU - Cooper, Dan M.

AU - Wilson, Archie F.

AU - George, Steven

PY - 2002/2/1

Y1 - 2002/2/1

N2 - Exhaled nitric oxide (NO) remains a promising noninvasive index for monitoring inflammatory lung diseases; however, the plateau concentration (CNo,plat) is nonspecific and requires a constant exhalation flow rate. We utilized a new technique that employs a variable flow rate to estimate key flow-independent parameters characteristic of NO exchange in a group (n = 9) of 10 to 14 yr-old healthy children and children with cystic fibrosis (CF). maximum flux of NO from the airways (JNo,max, pl s-1), diffusing capacity of NO in the airways (DNo,air, pl s-1 ppb-1), steady-state alveolar concentration (Calv,ss, ppb), and mean tissue concentration of NO in the airways (Ctiss,air, ppb). We determined the following mean (± SD) values in the healthy children and patients with CF for JNo,max, DNo,air, C̄alv,ss, and C̄tiss,air, respectively; 784 ± 465 and 607 ± 648 pl s-1; 4.82 ± 3.07 and 17.6 ± 12.1 pl s-1 ppb-1; 4.63 ± 3.59 and 1.96 ± 1.18 ppb; and 198 ± 131 and 38 ± 25 ppb. DNo,air is elevated (p = 0.007), and both Calv,ss and C̄tiss,air are reduced (p = 0.05 and 0.002, respectively) in CF. In contrast, CNO,plat for healthy control subjects and patients with CF are not statistically different at both exhalation flow rates of 50 ml/s (17.5 ± 11.5 and 11.5 ± 8.97) and at 250 ml/s (7.11 ± 5.36 and 4.28 ± 3.43). We conclude that DNo,air, C̄tiss,air, and Calv,ss may be useful noninvasive markers of CF.

AB - Exhaled nitric oxide (NO) remains a promising noninvasive index for monitoring inflammatory lung diseases; however, the plateau concentration (CNo,plat) is nonspecific and requires a constant exhalation flow rate. We utilized a new technique that employs a variable flow rate to estimate key flow-independent parameters characteristic of NO exchange in a group (n = 9) of 10 to 14 yr-old healthy children and children with cystic fibrosis (CF). maximum flux of NO from the airways (JNo,max, pl s-1), diffusing capacity of NO in the airways (DNo,air, pl s-1 ppb-1), steady-state alveolar concentration (Calv,ss, ppb), and mean tissue concentration of NO in the airways (Ctiss,air, ppb). We determined the following mean (± SD) values in the healthy children and patients with CF for JNo,max, DNo,air, C̄alv,ss, and C̄tiss,air, respectively; 784 ± 465 and 607 ± 648 pl s-1; 4.82 ± 3.07 and 17.6 ± 12.1 pl s-1 ppb-1; 4.63 ± 3.59 and 1.96 ± 1.18 ppb; and 198 ± 131 and 38 ± 25 ppb. DNo,air is elevated (p = 0.007), and both Calv,ss and C̄tiss,air are reduced (p = 0.05 and 0.002, respectively) in CF. In contrast, CNO,plat for healthy control subjects and patients with CF are not statistically different at both exhalation flow rates of 50 ml/s (17.5 ± 11.5 and 11.5 ± 8.97) and at 250 ml/s (7.11 ± 5.36 and 4.28 ± 3.43). We conclude that DNo,air, C̄tiss,air, and Calv,ss may be useful noninvasive markers of CF.

KW - Airways

KW - Healthy children

KW - Inflammation

KW - Nitric oxide

KW - Parameter estimation

UR - http://www.scopus.com/inward/record.url?scp=0036469034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036469034&partnerID=8YFLogxK

U2 - 10.1164/ajrccm.165.3.2105098

DO - 10.1164/ajrccm.165.3.2105098

M3 - Article

VL - 165

SP - 349

EP - 357

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -